Cross Linked Deep Type Hyaluronic Acid

Ingredient: 24mg/m hyaluronic acid

Specification: 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml

Package: Syringe

Recommended use: 1-3 pcs, 12 months apart

Application Area: Chin, nasal dorsum, nasal column and anterior nose 



Contact Now WhatsApp
Product Details

Product Introduction:

The HA gel portfolio features process-differentiated solutions: Tissue-integrating single gels for natural contours and high-lift double formulations requiring low injection force. With Super-grade D24+ lasting 9-12 months clinically, our products outpace American equivalents in persistence. Micro-crosslinked D12 demonstrates 92% patient satisfaction in fine wrinkle correction, while HD20's antioxidant formula reduces post-lip augmentation edema by 37% versus standard D20.


Product Display:

Cross Linked Deep Type Hyaluronic Acid


Product Details:

Type

Deep

Ingredient

Cross Linked Hyaluronic Acid Dermal Filler

Specification

1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml

Cross Link

BDDE chemical cross link

Texture

Gel

Elasticity

500 Pa-650 Pa

Viscosity

150 Pa-250 Pa

Mean particle size

400μm-600μm

Effective content

24mg/mL

Cross linker residue

No,or≤0.5ug/g

Protein residue

≤20μg/g

Endotoxin content

<0.5EU/mL

Swelling degree

20-40

Extruding force

20N-30N

Application area

Chin, nasal dorsum, nasal column and anterior nose

Package

Syringe

Stoarge

Room temperature (1-25ºC), cool and dry place

Recommended
Use quantity

1-3 pcs (vary with each individual

Recommended interval

12 month


Product Package:

Cross Linked Deep Type Hyaluronic Acid


Customer Feedback:


Customer Feedback

Customer Feedback


Raw Material Advantages:

1. In cosmetic formulations, CLHA maintains efficacy in high-humidity environments where linear HA would absorb excess moisture.

2. Cross-linked networks facilitate ionic binding of growth factors like TGF-β for localized regenerative therapies.

3. CLHA fillers with heterogeneous particle sizes enable multi-layered tissue augmentation strategies.


Development Process:

Development Process


Company Introduction:

A leader in biomedical innovation since 2014, Jinan Grandwill develops implant-grade materials and medical cosmetics through advanced R&D. Our 5,000-sqm production base features 6 specialized lines, including prefilled syringes and high-pressure sterilization systems. With 7 invention patents and 4 utility models, our ISO 9001-certified processes ensure chemical purity, stability, and compliance with global safety standards.

Leave your messages

Related Products

x

Popular products

x